Giancarlo Pruneri
Giancarlo Pruneri
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Kathryn P Gray
Kathryn P Gray
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Andrea Vingiani
Andrea Vingiani
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Giuseppe Viale
Giuseppe Viale
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Giuseppe Curigliano
Giuseppe Curigliano
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Carmen Criscitiello
Carmen Criscitiello
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
István Láng
István Láng
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Thomas Ruhstaller
Thomas Ruhstaller
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Lorenzo Gianni
Lorenzo Gianni
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Aron Goldhirsch
Aron Goldhirsch
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Roswitha Kammler
Roswitha Kammler
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Karen N Price
Karen N Price
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Giuseppe Cancello
Giuseppe Cancello
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Elisabetta Munzone
Elisabetta Munzone
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Richard D Gelber
Richard D Gelber
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Meredith M Regan
Meredith M Regan
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,
Marco Colleoni
Marco Colleoni
1Giancarlo Pruneri. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giancarlo.pruneri@ieo.it
2Kathryn P. Gray. International Breast Cancer Study Group (IBCSG) Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. pkruan@jimmy.harvard.edu
3Andrea Vingiani. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. andrea.vingiani@unimi.it
4Giuseppe Viale. Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.viale@ieo.it
5Giuseppe Curigliano. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.curigliano@ieo.it
6Carmen Criscitiello. Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. carmen.criscitiello@ieo.it
7István Láng. National Institute of Oncology, Budapest, Hungary. Ráth György u. 7/9, H-1122 Budapest, Hungary. lang@oncol.hu
8Thomas Ruhstaller. Breast Center St. Gallen, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. Kantonsspital St. Gallen 9007, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch
9Lorenzo Gianni. Divisione di Oncologia, Ospedale degli Infermi, Rimini, Italy. Viale Settembrini 2 47923, Rimini, Italy. lorenzo.gianni@auslromagna.it
10Aron Goldhirsch. Program for Breast Health, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. aron.goldhirsch@ibcsg.org
11Roswitha Kammler. International Breast Cancer Study Group, Translational Research Coordination and Central Pathology Office, IBCSG Coordinating Center, Bern, Switzerland. Effingerstrasse 40 CH-3008, Bern, Switzerland. Rosita.Kammler@ibcsg.org
12Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. price@jimmy.harvard.edu
13Giuseppe Cancello. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. giuseppe.cancello@ieo.it
14Elisabetta Munzone. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. elisabetta.munzone@ieo.it
15Richard D. Gelber. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. gelber@jimmy.harvard.edu
16Meredith M. Regan. IBCSG Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 450 Brookline Avenue, Boston, MA 02215, USA. mregan@jimmy.harvard.edu
17Marco Colleoni. Division of Medical Senology, European Institute of Oncology, Milan, Italy. Via Ripamonti 435, Milan, 20141, Italy. marco.colleoni@ieo.it
1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17